Clinical trial
A Pilot Study on Transplantation Therapy Using Autologous Bone Marrow Mononuclear Cells and Umbilical Cord Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus
NCT01143168 is registered in ClinicalTrials.gov with Cellonis Biotechnology Co. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study on Transplantation Therapy Using Autologous Bone Marrow Mononuclear Cells and Umbilical Cord Mesenchymal Stem Cells in Patients With Type 1 Diabetes Mellitus
- Lead sponsor
- Cellonis Biotechnology Co. Ltd.
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- August 31, 2010
- Completion date
- December 31, 2011
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
type 1 diabetes mellitus